Are you eligible?
Ready to improve your sleep?
Ready to join the path to restful nights? We are happy to help you start enjoying life to the fullest again. Answer a few of these questions to check if you are eligible for the therapy.
Genio reinvents sleep
Genio is the world`s first and unique battery-free, leadless and single incision neurostimulator that was designed and developed with the user in mind.
The Genio system is used to treat patients suffering from moderate to severe Obstructive Sleep Apnea (OSA), defined as AHI of greater or equal to 15 and less than or equal to 65 with and without Complete Concentric Collapse (CCC) at the soft palate level.
The Genio system is used in adult patients who have not tolerated, have failed or refused Positive Airway Pressure (PAP) treatments. PAP failure is defined as an inability to eliminate OSA (AHI of greater than 15 despite PAP usage) and PAP intolerance is defined as:
A) Inability to use PAP (less than 5 nights per week of usage; usage defined as 4 hours or more of use per night);
B) Or unwillingness to continue to use PAP (for example, a patient returns the PAP system after attempting to use it).
Patients eligible to use the Genio system can have a body mass index of up to 35kg/m².
The Genio system is CE-marked and a proven treatment for Obstructive Sleep Apnea. Depending on your region, the cost for the Genio therapy may or may not be covered by your health insurance. Please discuss with your doctor. Your physician will decide if you are eligible for the Genio system.
Genio has received CE mark in March 2019 and is approved for use in Europe. Investigational device in the United States. Limited by U.S. federal law to investigational use in the United States.